Remission of Tumor-Induced Hypoglycemia and Malignant Hypertension With the IgF-2 Inhibitor Pasireotide in Metastatic Adrenocortical Carcinoma (ACC): Remission of ACC With Pasireotide
AACE Endocrinology and Diabetes · 2026-10
DOI: 10.1016/j.aed.2026.09.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-10. Verfasst von Terri W. Jerkins und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jerkins, T. W., Bell, D. H., Bauer, T. M., & Jerkins, R. K. (2026). Remission of Tumor-Induced Hypoglycemia and Malignant Hypertension With the IgF-2 Inhibitor Pasireotide in Metastatic Adrenocortical Carcinoma (ACC): Remission of ACC With Pasireotide. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.09.021
Vancouver
Jerkins TW, Bell DH, Bauer TM, Jerkins RK. Remission of Tumor-Induced Hypoglycemia and Malignant Hypertension With the IgF-2 Inhibitor Pasireotide in Metastatic Adrenocortical Carcinoma (ACC): Remission of ACC With Pasireotide. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.09.021
BibTeX
@article{Jerkins2026,
author = {Jerkins, Terri W. and Bell, David H.S. and Bauer, Todd M. and Jerkins, Randy K.},
title = {Remission of Tumor-Induced Hypoglycemia and Malignant Hypertension With the IgF-2 Inhibitor Pasireotide in Metastatic Adrenocortical Carcinoma (ACC): Remission of ACC With Pasireotide},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.09.021}
}
EUVIMED